ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 149 filers reported holding ASCENDIS PHARMA A/S in Q1 2020. The put-call ratio across all filers is 0.46 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $266,312 | +76.6% | 2,844 | +130.3% | 0.00% | – |
Q4 2022 | $150,831 | -91.6% | 1,235 | -92.9% | 0.00% | -100.0% |
Q3 2022 | $1,793,000 | +219.0% | 17,365 | +187.3% | 0.00% | +300.0% |
Q2 2022 | $562,000 | +56100.0% | 6,044 | +54845.5% | 0.00% | – |
Q2 2021 | $1,000 | -96.7% | 11 | -95.2% | 0.00% | – |
Q1 2021 | $30,000 | -80.9% | 231 | -75.5% | 0.00% | – |
Q4 2020 | $157,000 | +145.3% | 941 | +65.4% | 0.00% | -100.0% |
Q1 2020 | $64,000 | -74.3% | 569 | -68.2% | 0.00% | -50.0% |
Q4 2019 | $249,000 | +111.0% | 1,788 | +46.2% | 0.00% | +100.0% |
Q3 2019 | $118,000 | -81.8% | 1,223 | -78.2% | 0.00% | -83.3% |
Q2 2019 | $647,000 | +670.2% | 5,615 | +317.5% | 0.01% | +500.0% |
Q4 2018 | $84,000 | +1100.0% | 1,345 | +1272.4% | 0.00% | – |
Q2 2018 | $7,000 | – | 98 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 2,046,832 | $240,912,000 | 24.02% |
RA Capital Management | 4,132,442 | $486,388,000 | 20.97% |
VHCP Management II, LLC | 504,210 | $59,346,000 | 17.36% |
Ghost Tree Capital, LLC | 385,000 | $45,315,000 | 11.84% |
Sofinnova Investments, Inc. | 998,538 | $117,528,000 | 11.33% |
Foresite Capital Management IV, LLC | 245,424 | $28,886,000 | 10.38% |
Avoro Capital Advisors LLC | 1,795,000 | $211,272,000 | 9.14% |
Orbimed Advisors | 3,970,673 | $467,348,000 | 7.24% |
Eventide Asset Management | 1,698,648 | $199,931,000 | 6.88% |
Foresite Capital Management III, LLC | 204,088 | $24,021,000 | 6.25% |